Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

32.95
Delayed Data
As of Jun 26
 +0.34 / +1.04%
Today’s Change
27.60
Today|||52-Week Range
56.44
-9.10%
Year-to-Date
These Stocks Are Changing Course
Jun 26 / TheStreet.com - Paid Partner Content
Glaxo's (GSK) Shingles Candidate Phase III Data Positive
Jun 22 / Zacks.com - Paid Partner Content
Allergan Continues to Focus on Acquisitions and Branded Unit
Jun 26 / Zacks.com - Paid Partner Content
FDA Commisoner Takes on Big Pharma
Jun 21 / TheStreet.com - Paid Partner Content
Teva Ready for Higher Prices
Jun 23 / TheStreet.com - Paid Partner Content
Ohio blames drugmakers for fueling opioid crisis
Jun 01 / CNNMoney.com

Today’s Trading

Previous close32.61
Today’s open32.81
Day’s range32.77 - 33.41
Volume6,896,511
Average volume (3 months)7,732,443
Market cap$33.1B
Dividend yield4.13%
Data as of 06/26/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-6.33%
Earnings growth (next 5 years)+0.35%
Revenue growth (last year)+12.01%
P/E ratio1,647.5
Price/Sales1.59
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.70+1.56%
OASMOasmia Pharmaceutica...-0.05-4.55%
Data as of 06/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$1.13
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Yitzhak Peterburg
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts